Metabolic syndrome : underlying mechanisms and drug therapies / / edited by Minghan Wang.
Saved in:
| : | |
|---|---|
| TeilnehmendeR: | |
| Year of Publication: | 2011 |
| Language: | English |
| Online Access: | |
| Physical Description: | xiii, 494 p. :; ill. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 03278nam a2200373 a 4500 | ||
|---|---|---|---|
| 001 | 500698739 | ||
| 003 | MiAaPQ | ||
| 005 | 20200520144314.0 | ||
| 006 | m o d | | ||
| 007 | cr cn||||||||| | ||
| 008 | 100507s2011 njua sb 001 0 eng d | ||
| 010 | |z 2010019505 | ||
| 020 | |z 9780470343425 (cloth) | ||
| 020 | |a 9780470910009 (electronic bk.) | ||
| 035 | |a (MiAaPQ)500698739 | ||
| 035 | |a (Au-PeEL)EBL698739 | ||
| 035 | |a (CaPaEBR)ebr10441458 | ||
| 035 | |a (CaONFJC)MIL288898 | ||
| 035 | |a (OCoLC)696237308 | ||
| 040 | |a MiAaPQ |c MiAaPQ |d MiAaPQ | ||
| 050 | 4 | |a RC662.4 |b .M53 2011 | |
| 082 | 0 | 4 | |a 616.3/99 |2 22 |
| 245 | 0 | 0 | |a Metabolic syndrome |h [electronic resource] : |b underlying mechanisms and drug therapies / |c edited by Minghan Wang. |
| 260 | |a Hoboken, N.J. : |b John Wiley & Sons, |c c2011. | ||
| 300 | |a xiii, 494 p. : |b ill. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Gut as an endocrine organ : the role of nutrient-sensing in energy metabolism / Minghan Wang -- Central glucose sensing and control of food intake and energy homeostasis / Lourdes Mounien and Bernard Thorens -- Abnormalities in insulin secretion in type 2 diabetes mellitus / Taly Meas and Pierre-Jean Guillausseau -- Adipokine production by adipose tissue : a novel target for treating metabolic syndrome and its sequelae / Vanessa DeClercq ... [et al.] -- Hepatic metabolic dysfunctions in type 2 diabetes : insulin resistance and impaired glucose production and lipid synthesis / Ruojing Yang -- Energy metabolism in skeletal muscle and its link to insulin resistance / Minghan Wang -- Mechanisms and complications of metabolic syndrome / Minghan Wang -- Emerging therapeutic approaches for dyslipidemia associated with high LDL and low HDL / Margrit Schwarz and Jae B. Kim -- Mechanism of action of niacin : implications for atherosclerosis and drug discovery / Devan Marar ... [et al.] -- Current anti-diabetic therapies and mechanisms / Minghan Wang -- GLP-1 biology, signaling mechanisms, physiology, and clinical studies / Remy Burcelin ... [et al.] -- Dipeptidyl peptidase IV inhibitors for treatment of diabetes / McIntosh, C.H.S. ... [et al.] -- Sodium glucose co-transporter 2 inhibitors / Margaret Ryan and Serge A. Jabbour -- Fibroblast growth factor 21 as a novel metabolic regulator / Radmila Micanovic, James D. Dunbar, and Alexei Kharitonenkov -- Sirtuins as potential drug targets for metabolic diseases / Qiang Tong -- 11-hydroxysteroid dehydrogenase type 1 as a therapeutic target for type 2 diabetes / Clarence Hale and David J. St. Jean, Jr -- Monoclonal antibodies for the treatment of type 2 diabetes : a case study with glucagon receptor blockade / Hai Yan, Wei Gu, and Murielle Veniant-Ellison -- Drug development for metabolic diseases: past, present and future / Minghan Wang. | |
| 533 | |a Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. | ||
| 650 | 0 | |a Metabolic syndrome |x Pathophysiology. | |
| 650 | 0 | |a Metabolic syndrome |x Chemotherapy. | |
| 655 | 4 | |a Electronic books. | |
| 700 | 1 | |a Wang, Minghan, |d 1966- | |
| 710 | 2 | |a ProQuest (Firm) | |
| 856 | 4 | 0 | |u https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=698739 |z Click to View |